Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Whether there’s a family history of neurofibromatosis 1 (NF1) or the diagnosis comes straight out of the blue, no parents are ever ready to learn that their child has a chronic and unpredictable condition. Many are left feeling overwhelmed, confused and uncertain. If this has happened to your family, we’d like you to keep in mind two things:
Many families have been down this path and learned how to help their children thrive, and you will too. Here at Boston Children’s Hospital, there are lots of ways we can help.
There’s a wide range of ways that NF1 can affect a child with the condition, but most kids don’t have the most serious complications and will lead healthy, productive lives.
Neurofibromatosis 1 is a genetic condition that causes symptoms including tumors (called neurofibromas) formed from nerve tissue. While the tumors are usually benign (non-cancerous), they may be a concern if their location means that they’re pinching a nerve or otherwise interfering with other parts of the body.
How Boston Children’s Hospital approaches neurofibromatosis
Our multidisciplinary Neurofibromatosis (NF) Program is a specialized clinic within the Division of Genetics that offers comprehensive diagnostic evaluations, follow-up care and genetic counseling for children, teens and young adults. We see over 700 patients with suspected or confirmed neurofibromatosis each year. We offer:
Our program has been designated a Children’s Tumor Foundation NF Center of Excellence, and as a member of the Harvard Medical School Center for Neurofibromatosis and Allied Disorders (CNfAD), our clinicians and researchers meet with colleagues from Massachusetts General Hospital and Dana-Farber Cancer Institute to discuss issues related to NF and host a yearly educational conference. Your child is in good hands with us.
Neurofibromatosis 1: Reviewed by Mira Irons, MD, and Nicole Ullrich, MD, PhD
© Boston Children’s Hospital, 2011
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”